MVST INVESTOR REMINDER: Microvast Holdings, Inc. Investors Have Until September 21, 2026 to Contact Kirby McInerney LLP to Seek Lead Plaintiff Role

NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your Microvast Holdings, Inc. (“Microvast” or the “Company”) (NASDAQ: MVST) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at [e-mail], or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

Investors have until September 21, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead plaintiffs, not only institutions. Learn more about the lead plaintiff process and eligibility requirements here.

[CONTACT THE FIRM IF YOU SUFFERED A LOSS]

What Is The Lawsuit About?

The lawsuit has been filed on behalf of investors who purchased securities during the period of April 1, 2025 and March 16, 2026, inclusive (“the Class Period”). The lawsuit alleges that Microvast made false and/or misleading statements and/or failed to disclose that: (i) due to, inter alia, inventory management issues and delays in commercial vehicle rollouts by Microvast’s customers, the Company had overstated its ability to reach its margin targets; and (ii) the Company had overstated its ability to complete the expansion of manufacturing facility located in Huzhou, China and increase its production capacity before the end of 2025.

Then, on August 1, 2025, Microvast announced the departure of its Chief Financial Officer, Carl T. Schultz, three months after he joined the Company. On this news, Microvast’s stock price fell $0.30 per share, or almost 10%, to close at $2.72 per share on August 4, 2025.

Then, on November 10, 2025, Microvast issued a press release reporting its financial and operating results for the quarter ended September 30, 2025, in which it revealed that production following the Huzhou Phase 3.2 expansion would not begin until Q1 2026 after having previously advised investors that the additional capacity associated with the expansion would be online by Q4 2025. On this news, Microvast’s stock price fell $0.50 per share, or approximately 10%, to close at $4.48 per share on November 11, 2025.

Finally, on March 16, 2026, Microvast issued a press release reporting its financial and operating results for the quarter and year ended December 31, 2025. Microvast reported that gross margin declined to approximately 1% for the quarter, down from approximately 36% for the same period in the prior year, which the Company attributed to inventory impairment charges arising from “specialized ESS components”. Microvast also reported revenue of $96.5 million for the quarter, representing a 15% year-over-year decrease and falling well short of the consensus estimate of $136.4 million. Microvast attributed this result to “regulatory shifts in South Korea and delays in customer platform ramp-up” in Europe, the Middle East, and Africa. On this news, Microvast’s stock price fell $0.79 per share, or over 34%, to close at $1.52 per share on March 17, 2026.

[CLICK HERE TO LEARN MORE ABOUT THE CLASS ACTION]

What Should I Do?

If you purchased or otherwise acquired Microvast securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at [e-mail], or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.

[WHAT IS A SECURITIES CLASS ACTION?]

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.